Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%) Natco Pharma - Quaterly Results
Date: 11-11-2021
The sales is pegged at Rs. 3304.00 millions for the September 2021 quarter. The mentioned figure indicates a decline of about -31.01% as against Rs. 4789.00 millions during the year-ago period.Net profit declined -24.40% to Rs. 536.00 millions from Rs. 709.00 millions.Operating profit for the quarter ended September 2021 decreased to 897.00 millions as compared to 1176.00 millions of corresponding quarter ended September 2020.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202109 | 202009 | % Var | 202109 | 202009 | % Var | 202103 | 202003 | % Var | |
| Sales | 3304.00 | 4789.00 | -31.01 | 7242.00 | 10111.00 | -28.38 | 16535.00 | 17902.00 | -7.64 |
| Other Income | 403.00 | 272.00 | 48.16 | 526.00 | 471.00 | 11.68 | 1011.00 | 1238.00 | -18.34 |
| PBIDT | 897.00 | 1176.00 | -23.72 | 2156.00 | 3101.00 | -30.47 | 5187.00 | 7018.00 | -26.09 |
| Interest | 32.00 | 27.00 | 18.52 | 50.00 | 60.00 | -16.67 | 113.00 | 206.00 | -45.15 |
| PBDT | 865.00 | 1149.00 | -24.72 | 2106.00 | 3041.00 | -30.75 | 5074.00 | 6812.00 | -25.51 |
| Depreciation | 342.00 | 284.00 | 20.42 | 673.00 | 560.00 | 20.18 | 1152.00 | 981.00 | 17.43 |
| PBT | 523.00 | 865.00 | -39.54 | 1433.00 | 2481.00 | -42.24 | 3922.00 | 5831.00 | -32.74 |
| TAX | -13.00 | 156.00 | -108.33 | 145.00 | 505.00 | -71.29 | 827.00 | 1086.00 | -23.85 |
| Deferred Tax | -113.00 | -50.00 | 126.00 | -110.00 | -115.00 | -4.35 | -106.00 | -205.00 | -48.29 |
| PAT | 536.00 | 709.00 | -24.40 | 1288.00 | 1976.00 | -34.82 | 3095.00 | 4745.00 | -34.77 |
| Equity | 365.00 | 364.00 | 0.27 | 365.00 | 364.00 | 0.27 | 365.00 | 364.00 | 0.27 |
| PBIDTM(%) | 27.15 | 24.56 | 10.56 | 29.77 | 30.67 | -2.93 | 31.37 | 39.20 | -19.98 |